Rheinmetalls, Ambulance

Rheinmetall's Ambulance Backlog Grows, But the Share Price Story Remains Stuck in the Trenches

Published on 08/18/2026 at 14:22 | Redaktion boerse-global.de

Rheinmetall books €500M+ order for 149 mobile rescue stations, but shares remain 39% below peak; JPMorgan stays neutral with €1,350 target.

Rheinmetall Secures €500M Rescue Station Order, Stock Still 39% Below High
Rheinmetall Illustration mit AI erstellt übermittelt durch boerse-global.de

The German armed forces have placed another substantial order with Rheinmetall, calling up 149 additional mobile rescue stations worth more than €500 million gross. The move, confirmed by the company on Monday, lifts the total order to 165 systems with a combined value exceeding €600 million — the largest single contract ever booked by the Rheinmetall Project Solutions division.

The order was pulled down in July under a framework agreement signed in December 2024, with production scheduled to begin in the first quarter of 2027. Each mobile rescue station consists of two self-sufficient containers that four soldiers can assemble and dismantle, allowing deployment in challenging terrain. A significant portion of the units also comes with ballistic protection, enabling operations closer to the front line.

Advertisement

Field hospitals and mobile rescue stations highlight how critical it is to have proper safety documentation in place — and the same principle applies to your own workplace. Many employers underestimate the dangerous gap in their occupational safety records. A free toolkit with 41 checklists and templates helps you document risks in a legally compliant way. Download the free Risk Assessment Toolkit

A Share Price Still Digging Out

Investors took the news in stride, nudging the stock roughly 1.5 percent higher to €1,221 on Monday before it settled at €1,217.00, a gain of 1.0 percent on the day. Yet that modest uptick does little to mask the deeper problem: the shares remain about 39 percent below their 52-week high of €2,007, reached in early October last year.

The technical picture reinforces the caution. The stock trades roughly 15 percent beneath its 200-day moving average of €1,437.95, a signal that the medium-term downtrend has yet to be broken despite the recent recovery. It has, however, crept back toward its 100-day average of €1,217.90, which now sits almost exactly at the current price level — a sign that the immediate selling pressure may be easing, even if the broader trajectory remains uncertain.

JPMorgan Stays on the Sidelines

The fresh contract does little to shift JPMorgan's stance. Analyst David Perry reaffirmed a "Neutral" rating with a price target of €1,350 on Monday, preferring other European defense names instead.

Perry's caution centers on revenue risks for the 2027–2030 period, with his estimates running as much as 17 percent below the market consensus. The concern is less about any single order and more about the long-term growth trajectory, which JPMorgan views more skeptically than other market participants. The bank's hesitation speaks to a fundamental question for investors: how sustainable is the current pace of order intake if defense budgets evolve differently than expected in the years ahead?

Beyond the Battlefield

The medical equipment contract is just one piece of a broader portfolio story. Rheinmetall is also modernizing the frigate Bayern for a mid-three-digit million euro sum, with work expected to run through 2029. Additional naval orders are considered possible, reinforcing the picture of a diversified order book that extends well beyond the land forces division.

The drone defense segment adds another layer. A drone incident in Leipzig in early August reignited the German debate over airspace security, with Rheinmetall — alongside Volatus Aerospace and DroneShield — cited as a potential beneficiary of a growing market for counter-drone systems. Concrete order figures from this field have yet to materialize, but the development underscores the breadth of a company often reduced to its ammunition and vehicle businesses.

Advertisement

Just as Rheinmetall diversifies across defense segments, your business needs comprehensive protection across all areas of workplace safety. Over 37,000 UK companies already trust a free Health & Safety Toolkit covering key regulations like the Health & Safety at Work Act 1974, COSHH, and PUWER. Protect your employees, visitors, and the public with ready-to-use risk assessments and checklists. Get the free Health & Safety Toolkit

A Split Screen for Investors

The result is a two-sided picture. Operationally, Rheinmetall continues to pile up evidence of a robust order pipeline, from field hospitals to frigate upgrades. The valuation question — whether that translates into a sustainable stock market turnaround — remains open, with JPMorgan's growth estimates for the coming years keeping the debate alive.

The broader sector offered little clarity last week: defense stocks traded unevenly while the DAX hit a record high before giving back some ground at the start of this week. For Rheinmetall shareholders, the contrast between the company's operational momentum and its share price trajectory remains the defining tension of the moment.

Disclaimer...

en | DE0007030009 | RHEINMETALLS | boerse | 69964461 |